Significance of anti-HBc screening of blood donors & its association with occult hepatitis B virus infection: Implications for blood transfusion

Indian Journal of Medical Research

Volumn 132, Issue 9, 2010, Pages 312-317

  Asim, Mohammad ^a,b   Ali, Riyasat ^b   Khan, Luqman A ^b   Husain, S A ^b   Singla, Rajiv ^a   Kar, P ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Anti; HBc screening; HBs titres; Occult HBV infection; Polymerase chain reaction (PCR); Volunteer blood donors

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; FEMALE; HEPATITIS B; HUMAN; INDIA; MALE; POLYMERASE CHAIN REACTION; TERTIARY HEALTH CARE; BLOOD; DISEASE TRANSMISSION; EPIDEMIOLOGY; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; MASS SCREENING; STANDARD;

BLOOD DONORS; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INDIA; MASS SCREENING; SEROEPIDEMIOLOGIC STUDIES;

EID: 77957080245     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Badur S, Akgun A. Diagnosis of hepatitis B infections and monitoring of treatment. J Clin Virol 2001; 21: 229-37.
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685-90.
3. Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K. Low- level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004; 14: 97-103.
4. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998; 27: 1377-82.
5. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and digestive and Kidney diseases liver Transplantation Database. Gastroenterology 1997; 113: 1668-74.
6. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, et al. Retrovirus Epidemiology Donors Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704.
7. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini- Brechot P, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34: 194-203.
8. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995; 35: 5-12.
9. Japanese Red Cross NAT Screening Research Group. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Jpn J Infect Dis 2000; 53: 116-23.
10. Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India. Hemodial Int 2005; 9: 362-6.
11. Vyas GN. Algorithm for safe blood with regard to transfusion acquired infections. In: Sarin SK, Hess G, editors. Transfusion associated hepatitis. Diagnosis, treatment and prevention. New Delhi: CBS Publishers & Distributors; 1998. p. 462-78.
12. [No authors listed]. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research group. Lancet 1991; 338: 1040-1.
13. Kramvis A, Bukofzer S, Kew MC. Comparison of hepatitis B virus DNA exractions from serum by the QIAamp blood kit, GeneReleaser, and the phenol-chloroform method. J Clin Microbiol 1996; 34: 2731-3.
14. Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol 2006; 78: 53-9.
15. Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T, et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion 2001; 41: 1093-9.
16. Badur S, Akgun A. Diagnosis of hepatitis B infections and monitoring of treatment. J Clin Virol 2001; 21: 229-37.
17. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001; 34: 204-6.
18. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006; 91: 1-12.
19. Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K. Low- level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004; 14: 97-103.
20. Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, et al. Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India. J Clin Virol 2007; 40: 312-7.
21. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007; 47: 74-9.
22. Zekri AR, Awlia AA, El Mahalawi H, Ismail EF, Mabrouk GM. Evaluation of blood units with isolated anti HBc for the presence of HBV DNA. Dis Markers 2002; 18: 107-10.
23. Khurana V, Kar P, Mansharamani N, Jain V, Kanodia A. Differences in hepatitis B markers between clinical and preclinical health care personnel. Trop Gastroenterol 1997; 18: 69-71.
24. Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003; 43: 1442-8.
25. Gartner BC, Jung W, Welsch C, Fischinger J, Schubert J, Zeuzem S, et al. Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc- positive patient after allogeneic stem cell transplantation. J Clin Virol 2007; 38: 146-8.
26. Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H, et al. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001; 41: 1107-13.
27. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, et al. Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704.
28. Duseja A, Sharma S, Subramanian PG, Agnihotri SK, Chakraborti A, Chawla Y. Occult hepatitis B virus (HBV) infection in healthy blood donors. Indian J Pathol Microbiol 2003; 46: 690-2.
29. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, et al. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion 2007; 47: 1809-15.
30. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a look back program. Transfusion 2007; 47: 1197-205.
31. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007; 13: 3730-3.